Press release from Companies
Publicerat: 2021-05-26 07:00:00
Curasight A/S CEO Ulrich Krasilnikoff will present the company and its future plans at Bio Stock Life Science Spring Summit Thursday 27 May 2021. The presentation will be webcasted live 11:20 (CET), Thursday 27 May 2021.
For more information – please click here For more information regarding Curasight, please contact: Ulrich Krasilnikoff, CEO Phone: +45 22 83 01 60 E-mail: uk@curasight.com Curasight is a clinical development company based in Copenhagen, Denmark. The company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (“uPAR”). The technology is expected to improve diagnosis and risk stratification in multiple cancer types.
